Polyinosinic:polycytidylic acid

Synthetic analog of double-stranded RNA

Polyinosinic:polycytidylic acid (commonly abbreviated as poly I:C) is a synthetic analog of double-stranded RNA (dsRNA). It is composed of a strand of polyinosinic acid and a strand of polycytidylic acid, which form a double-stranded structure similar to that of viral RNA. Poly I:C is widely used in research to mimic viral infections and to study the immune response, particularly the activation of the innate immune system.

Structure and Composition

Poly I:C is a synthetic polynucleotide, consisting of two complementary strands: one made of inosine residues and the other of cytidine residues. These strands are hydrogen-bonded to form a stable double helix. The structure of poly I:C resembles that of viral dsRNA, which is recognized by the immune system as a pathogen-associated molecular pattern (PAMP).

Mechanism of Action

Poly I:C is recognized by several pattern recognition receptors (PRRs) in the immune system, including Toll-like receptor 3 (TLR3) and RIG-I-like receptors (RLRs). Upon binding to these receptors, poly I:C triggers signaling pathways that lead to the production of type I interferons and other cytokines, which are crucial for antiviral defense.

Toll-like Receptor 3

TLR3 is an endosomal receptor that recognizes dsRNA. When poly I:C binds to TLR3, it activates the TRIF-dependent signaling pathway, leading to the activation of NF-κB and IRF3, transcription factors that induce the expression of interferons and pro-inflammatory cytokines.

RIG-I-like Receptors

RLRs, including RIG-I and MDA5, are cytoplasmic receptors that detect viral RNA. Poly I:C is primarily recognized by MDA5, which activates the MAVS signaling pathway, resulting in the production of type I interferons.

Applications in Research

Poly I:C is extensively used in research to study the immune response to viral infections. It serves as a model for viral dsRNA, allowing researchers to investigate the mechanisms of innate immunity and the role of interferons in antiviral defense. Poly I:C is also used in cancer research to stimulate the immune system and enhance the efficacy of immunotherapy.

Therapeutic Potential

Due to its ability to activate the immune system, poly I:C has been explored as a potential therapeutic agent in the treatment of viral infections and cancer. It has been used in clinical trials as an adjuvant to boost the immune response in vaccines and as a direct antiviral agent.

Safety and Side Effects

While poly I:C is a powerful immune stimulant, it can also cause significant side effects, including inflammation, fever, and cytokine release syndrome. These effects limit its use in clinical settings, and research is ongoing to develop safer analogs and delivery methods.

Related Pages

• Double-stranded RNA
• Toll-like receptor 3
• RIG-I-like receptors
• Type I interferons
• Immunotherapy